EEB304 LECT17 MedicinalPlants Spring11

  • Upload
    asnar

  • View
    218

  • Download
    0

Embed Size (px)

Citation preview

  • 7/30/2019 EEB304 LECT17 MedicinalPlants Spring11

    1/40

    Thursday LectureMedicinal Plants

    Reading: Textbook, Chapter 11

  • 7/30/2019 EEB304 LECT17 MedicinalPlants Spring11

    2/40

    Margarinemade from fats

    - originally from animal fats- white in color, so yellow dye added to create appearance of

    butter

    Advantage: Stores better than butter

    Dairy Industryfought against use of margarine

    - Taxes

    - Regulations against sale; against use of dyes

    Wisconsinprohibited sale of colored margarineRepealed

    1967; + heavy tax on uncolored (white) margarine (people

    would buy and mix their own coloring agent)

  • 7/30/2019 EEB304 LECT17 MedicinalPlants Spring11

    3/40

    Quiz

  • 7/30/2019 EEB304 LECT17 MedicinalPlants Spring11

    4/40

    Quiz

    1. Name two of the four major vegetable oil crops.

    2. Name a medicinal plant, and tell what medicine isobtained from it and a disease it is used to treat

    3. What does soap have to do with vegetable oil?

  • 7/30/2019 EEB304 LECT17 MedicinalPlants Spring11

    5/40

    History - Highlights2500 BCSumerian use of opium poppy Fig. 11.2, p. 263

  • 7/30/2019 EEB304 LECT17 MedicinalPlants Spring11

    6/40

    History - Highlights2500 BCSumerian use of opium poppy

    1770 BCCode of Hammurabi in Babylonmentions plants

    Fig. 11.2, p. 263

  • 7/30/2019 EEB304 LECT17 MedicinalPlants Spring11

    7/40

    History - Highlights2500 BCSumerian use of opium poppy

    1770 BCCode of Hammurabi in Babylonmentions plants

    1550 BCEbers papyrus in Egypt700+ medicinal formulas

    Fig. 11.2, p. 263

  • 7/30/2019 EEB304 LECT17 MedicinalPlants Spring11

    8/40

    History - Highlights2500 BCSumerian use of opium poppy

    1770 BCCode of Hammurabi in Babylonmentions plants

    1550 BCEbers papyrus in Egypt700+ medicinal formulas

    400 BCHippocrates (Greece)Father of Medicine

    300 BCTheophrastus, Botanical Gardens in Athens

    Fig. 11.2, p. 263

  • 7/30/2019 EEB304 LECT17 MedicinalPlants Spring11

    9/40

    History - Highlights2500 BCSumerian use of opium poppy

    1770 BCCode of Hammurabi in Babylonmentions plants

    1550 BCEbers papyrus in Egypt700+ medicinal formulas

    400 BCHippocrates (Greece)Father of Medicine

    300 BCTheophrastus, Botanical Gardens in Athens

    77 ADDioscorides, De Materia Medica

    Fig. 11.2, p. 263

  • 7/30/2019 EEB304 LECT17 MedicinalPlants Spring11

    10/40

    History - Highlights2500 BCSumerian use of opium poppy

    1770 BCCode of Hammurabi in Babylonmentions plants

    1550 BCEbers papyrus in Egypt700+ medicinal formulas

    400 BCHippocrates (Greece)Father of Medicine

    300 BCTheophrastus, Botanical Gardens in Athens

    77 ADDioscorides, De Materia Medica

    Fig. 11.2, p. 263

  • 7/30/2019 EEB304 LECT17 MedicinalPlants Spring11

    11/40

    HistoryHighlights II

    1500 ADAge of herbalism, ParacelsusDoctrine of Signatures

  • 7/30/2019 EEB304 LECT17 MedicinalPlants Spring11

    12/40

    HistoryHighlights II

    1500 ADAge of herbalism, ParacelsusDoctrine of Signatures

    1775 ADDr. William WitheringFoxglove extracts

  • 7/30/2019 EEB304 LECT17 MedicinalPlants Spring11

    13/40

    HistoryHighlights II

    1500 ADAge of herbalism, ParacelsusDoctrine of Signatures

    1775 ADDr. William WitheringFoxglove extracts

    1900 ADHalf of drugs in U.S. Pharmacopeia still derived

    directly from plants

  • 7/30/2019 EEB304 LECT17 MedicinalPlants Spring11

    14/40

    HistoryHighlights II

    1500 ADAge of herbalism, ParacelsusDoctrine of Signatures

    1775 ADDr. William WitheringFoxglove extracts

    1900 ADHalf of drugs in U.S. Pharmacopeia still derived

    directly from plants

    1900sadvent of scientific medicine

  • 7/30/2019 EEB304 LECT17 MedicinalPlants Spring11

    15/40

    HistoryHighlights II

    1500 ADAge of herbalism, ParacelsusDoctrine of Signatures

    1775 ADDr. William WitheringFoxglove extracts

    1900 ADHalf of drugs in U.S. Pharmacopeia still derived

    directly from plants

    1900sadvent of scientific medicine

    2000Alternative medicine; concern for biodiversity

  • 7/30/2019 EEB304 LECT17 MedicinalPlants Spring11

    16/40

    Plant-Derived Medicines

    Major Classes of Compounds:

    1. Steroids

  • 7/30/2019 EEB304 LECT17 MedicinalPlants Spring11

    17/40

    Plant-Derived Medicines

    Major Classes of Compounds:

    1. Steroids

    2. Alkaloids

  • 7/30/2019 EEB304 LECT17 MedicinalPlants Spring11

    18/40

    Plant-Derived Medicines

    Major Classes of Compounds:

    1. Steroids

    2. Alkaloids

    Useful terms:

    Secondary Compound

    Glycoside

  • 7/30/2019 EEB304 LECT17 MedicinalPlants Spring11

    19/40

    Steroids - ChemistryFig. 11.5, p. 271

  • 7/30/2019 EEB304 LECT17 MedicinalPlants Spring11

    20/40

    Steroids - ChemistryFig. 11.5, p. 271

  • 7/30/2019 EEB304 LECT17 MedicinalPlants Spring11

    21/40

    Steroids - Chemistry

  • 7/30/2019 EEB304 LECT17 MedicinalPlants Spring11

    22/40

    Alkaloids - Chemistry

    1. Organic compound, with N, usually in ring structure

    Fig. 11.7, p. 272

  • 7/30/2019 EEB304 LECT17 MedicinalPlants Spring11

    23/40

    Alkaloids - Chemistry

    1. Organic compound, with N, usually in ring structure2. Physiologically active on vertebrate nervous systems

    Fig. 11.7, p. 272

  • 7/30/2019 EEB304 LECT17 MedicinalPlants Spring11

    24/40

    Alkaloids - Chemistry

    1. Organic compound, with N, usually in ring structure2. Physiologically active on vertebrate nervous systems

    Diverse class of compounds Fig. 11.7, p. 272

  • 7/30/2019 EEB304 LECT17 MedicinalPlants Spring11

    25/40

    Alkaloids - Chemistry

    1. Organic compound, with N, usually in ring structure2. Physiologically active on vertebrate nervous systems

    Diverse class of compounds Fig. 11.7, p. 272

  • 7/30/2019 EEB304 LECT17 MedicinalPlants Spring11

    26/40

    Examples of Plant Medicines

    Fig. 11.12, p. 276

    1900over half of drugs in U.S. Pharmacopeia from plants

    2001about 25% of drugs in U.S. Pharmacopeia from plants,but many synthetic compounds are based on plant-produced

    structures, or start with plant materials

    Anasthetics, analgesics, heart medicines, laxatives, muscle

    relaxants etc.

  • 7/30/2019 EEB304 LECT17 MedicinalPlants Spring11

    27/40

    Chaulmoogra Oil -Hydnocarpus

    Leprosybacterial disease, affects sensitive individuals

    Chaulmoogra oilfirst effective treatment

    Active

    ingredient

    seed oil

    Now replaced

    with antibiotics

    Fig. 11.8, p. 273

  • 7/30/2019 EEB304 LECT17 MedicinalPlants Spring11

    28/40

    Malaria - Cinchona Fig. 11.9, p. 274

    Malariacaused by protozoan

    Cinchona = Jesuits Bark

  • 7/30/2019 EEB304 LECT17 MedicinalPlants Spring11

    29/40

    Cinchona - bark of Peru; yellow bark

    About 40 species - Andean area of South America

    Native Grown

    Stolen by British, Dutch

    S li A i i

  • 7/30/2019 EEB304 LECT17 MedicinalPlants Spring11

    30/40

    Salix - AspirinHippocrates (Greece)used willow bark to treat pain

    S li A i i

  • 7/30/2019 EEB304 LECT17 MedicinalPlants Spring11

    31/40

    Salix - AspirinHippocrates (Greece)used willow bark to treat pain

    1897Bayer Co. (Germany) Chemistsynthesizes, names aspirin

    S li A i i

  • 7/30/2019 EEB304 LECT17 MedicinalPlants Spring11

    32/40

    Salix - AspirinHippocrates (Greece)used willow bark to treat pain

    1897Bayer Co. (Germany) Chemistsynthesizes, names aspirin

    Di t id

  • 7/30/2019 EEB304 LECT17 MedicinalPlants Spring11

    33/40

    Dioscorea steroids

    Wild Yamconvenient source for

    steroidal saponins which can be

    converted into synthetic hormones

    for use in contraceptives

    Fig. 11.13, p. 277

    P Alk l id

  • 7/30/2019 EEB304 LECT17 MedicinalPlants Spring11

    34/40

    PapaverAlkaloids Fig. 11.6, p. 279

    Catharanthus poster child for

  • 7/30/2019 EEB304 LECT17 MedicinalPlants Spring11

    35/40

    Catharanthusposter child for

    plant-derived medicines

    Effective drugs vs. lymphomas

    (Hodgkins disease)

    Fig. 11.22, p. 282

    N D D l t

  • 7/30/2019 EEB304 LECT17 MedicinalPlants Spring11

    36/40

    New Drug Development

    average to develop a new drug in U.S. - $231 million/12 years

    -> many not developed, if patent protection not available, or if market not assured

    Comparison:

    Germany - "reasonable certainty" of safety and effectivenessU.S. - "absolute proof"

    -> some modern herbal preparations coming from Europe, sold asdietary supplements in U.S.

    Examples: St. John's Wort, Echinacea, Gingko

  • 7/30/2019 EEB304 LECT17 MedicinalPlants Spring11

    37/40

    Looking for new drugs - General parameters:

    1 in 10,000 chemicals screened -> new drug product

    Development of new drug in U.S. - 12 years/$231 million(average)

    Many drugs/diseases - not pursued because of lack of

    profitability

  • 7/30/2019 EEB304 LECT17 MedicinalPlants Spring11

    38/40

    Development of Phy 906Phytoceutica

    Herbal medicine

    Based on Chinese Traditional Medicine

    Mixture of herbs: scutellaria (skullcap), glycyrrhiza (licorice),ziziphus (jujube), Paeonia (peony)

    Application: treat nausea and pain associated with cancer

    chemotherapy regimes

    Initial results: not only effective against side effects, but also

    appears to increase efficacy of chemotherapy for certain cancers

  • 7/30/2019 EEB304 LECT17 MedicinalPlants Spring11

    39/40

    Problems in Development of Rain Forest Drugs

    International Agreements

    (1) Discovery

    - by pharmaceutical companies

    - preceded by traditional healers

    Who discovered/Who should benefit financially?

    (2) Ownership - seeds, genes, chemicals

    cycle:

    Gene poor country, has scientific expertise

    -> Gene rich country, has genetic diversity but lacks science

    -> development of chemical by gene poor country

    -> now sell back to gene rich/economically poor country

    Tuesday Lecture Psychoactive and

  • 7/30/2019 EEB304 LECT17 MedicinalPlants Spring11

    40/40

    Tuesday LecturePsychoactive and

    Poisonous Plants

    Reading: Textbook, Chapter 12